{"prediction": {"id": "0f6c1d42-e4cb-55fc-b263-1f04d12a47a8", "work_id": "71d06e14-26f3-5880-90f0-cf7252b3141e", "study_id": "1d01b386-829b-58f9-8fd1-523c12ea3500", "kind": "External cohort model evaluation", "pages": [5], "version": "Version of record", "source_work_id": "71d06e14-26f3-5880-90f0-cf7252b3141e", "title": "Causal AI-based clinical and radiomic analysis for optimizing patient selection in combined immunotherapy and SABR in early-stage NSCLC: a secondary analysis of the phase II I-SABR trial.", "doi": "10.1136/jitc-2025-013074", "pdf_sha256": "7675cfb8e15fd3174e14307941e7f7a010dc4f29b1657cd51a5527432a3d011c", "physical_page_count": 11}, "fields": {"endpoint": {"value": "survival_event_free__hazard_ratio", "source_basis": "original_pdf_review", "pages": [5]}, "evaluation_scope": {"value": "external_validation", "source_basis": "verified_profile", "pages": [1, 5]}, "family": {"value": "clinical_outcomes", "source_basis": "verified_profile", "pages": [5]}, "measured_variable": {"value": "survival_event_free", "source_basis": "original_pdf_review", "pages": [5, 6]}, "measurement_role": {"value": "clinical_outcome", "source_basis": "original_pdf_review", "pages": [5]}, "metric": {"value": "hazard_ratio", "source_basis": "original_pdf_review", "pages": [5]}, "result_operation": {"value": "survival_association", "source_basis": "original_pdf_review", "pages": [5]}, "role": {"value": "clinical_outcome", "source_basis": "verified_profile", "pages": [5]}, "scenario": {"value": "external_validation", "source_basis": "original_pdf_review", "pages": [1, 5]}, "unit": {"value": "dimensionless", "source_basis": "verified_profile", "pages": [5]}}, "endpoints": [{"term": "risk_estimate", "label": "Risk and probability estimates"}, {"term": "survival", "label": "Survival and mortality"}], "validations": [], "model_resources": {"total": 1, "page": 1, "limit": 50, "rows": [{"id": 513, "work_id": "71d06e14-26f3-5880-90f0-cf7252b3141e", "claim_id": "0f6c1d42-e4cb-55fc-b263-1f04d12a47a8", "kind": "model", "label": "I-SABR-SELECT source for individualized treatment effects", "repository": "Author GitHub", "identifier": "WuLabMDA/ISABR-SELECT S1_Train_model.py", "source_page": 1, "availability": "author_reported_available", "url": "https://github.com/WuLabMDA/ISABR-SELECT", "scope": "claim_specific", "resource_version": null, "version_basis": null, "repository_commit": null, "repository_member": null, "source_file_sha256": null, "source_basis": "legacy_curated_resource", "priority": 2, "doi": "10.1136/jitc-2025-013074", "title": "Causal AI-based clinical and radiomic analysis for optimizing patient selection in combined immunotherapy and SABR in early-stage NSCLC: a secondary analysis of the phase II I-SABR trial.", "version": "Version of record", "pdf_sha256": "7675cfb8e15fd3174e14307941e7f7a010dc4f29b1657cd51a5527432a3d011c", "association_scope": "prediction", "resource_relation": "indexed_resource", "source_review": {"indexed": true, "source_basis": "legacy_curated_resource"}}], "review_status": "indexed_source"}}